Moderna Inc (NASDAQ:MRNA)
| 440.88 Delayed Data As of Sep 16 |  +6.19 / +1.42%Today’s Change | 63.64 Today|||52-Week Range 497.49 | +322.02% Year-to-Date |
Latest MRNA News | Press Releases
| Moderna (MRNA) Gains As Market Dips: What You Should Know Sep 16 / Zacks.com - Paid Partner Content | 3 Ultra-Popular Stocks With 81% to 98% Downside, According to Wall Street Sep 16 / MotleyFool.com - Paid Partner Content |
| Why Moderna and BioNTech Topped the Market Today Sep 16 / MotleyFool.com - Paid Partner Content | Why AbCellera Biologics Stock Jumped 7% on Wednesday Sep 15 / MotleyFool.com - Paid Partner Content |
| Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet Sep 16 / Zacks.com - Paid Partner Content | Green Across the Board at Closing Bell Sep 15 / Zacks.com - Paid Partner Content |
| If You Invested $2,000 in Moderna Stock in 2019, This Is How Much You Would Have Today Sep 16 / MotleyFool.com - Paid Partner Content | 3 COVID Stocks That Might Double Soon Sep 15 / MotleyFool.com - Paid Partner Content |
| Here's Why You Should Retain QIAGEN (QGEN) Stock For Now Sep 16 / Zacks.com - Paid Partner Content | 5 Reasons to Buy Vertex Pharmaceuticals (VRTX) Stock Now Sep 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 434.46 |
| Today’s open | 431.21 |
| Day’s range | 429.00 - 446.64 |
| Volume | 10,107,389 |
| Average volume (3 months) | 14,901,805 |
| Market cap | $181.4B |
Data as of 5:34pm ET, 09/16/2021
Growth & Valuation
| Earnings growth (last year) | -26.08% |
| Earnings growth (this year) | +1,619.76% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | +1,234.34% |
| P/E ratio | 55.1 |
| Price/Sales | 49.59 |
| Price/Book | 69.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMGNAmgen | -0.77 | -0.35% |
| GILDGilead Sciences | -0.43 | -0.60% |
| ILMNIllumina Inc | +0.04 | +0.01% |
| BIIBBiogen | +0.48 | +0.16% |
Data as of 4:00pm ET, 09/16/2021
Financials
| Next reporting date | November 10, 2021 |
| EPS forecast (this quarter) | $9.43 |
| Annual revenue (last year) | $803.4M |
| Annual profit (last year) | -$747.1M |
| Net profit margin | -92.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
